SCOLR Pharma, Inc. Receives Deficiency Letter From FDA On Pseudoephedrine Application
Links shared publicly online about this topic.
- 445total visits
SCOLR Pharma, Inc. Receives Deficiency Letter From FDA On Pseudoephedrine Application
SCOLR Pharma, Inc. (OTC Bulletin Board: SCLR) announced it has received a letter from the Food and Drug Administration (FDA) identifying deficiencies regarding its Abbreviated New Drug Application
View full resource at medicalnewstoday.com
Tags: Asthma, Diet and Nutrition, Drug, Pharma, FDA, Decongestant, Sudafed
Most Recently Shared on March 12, 2011 at 12:05 pm By:
SCOLR Pharma, Inc. Receives Deficiency Letter From FDA On Pseudoephedrine Application http://mnt.to/3Sdt #pharma #pharmaceutical
Also Shared By:
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA
news-medical.net — “SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.” View full resource at news-medical.net
Most Recently Shared on March 14, 2011 at 8:46 am By:
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA: SCOLR Pharma, Inc. today announced it ... http://bit.ly/hHckcr
Advertisement
MNT Asthma News
@mnt_asthma
SCOLR Pharma, Inc. Receives Deficiency Letter From FDA On Pseudoephedrine Application http://mnt.to/3Sdt #asthma
1 year ago...